- Home
- ELEV vs BOWN Comparison
ELEV vs BOWN Comparison
Compare ELEV & BOWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELEV
- BOWN
- Stock Information
- Founded
- ELEV 2019
- BOWN 2023
- Country
- ELEV United States
- BOWN United States
- Employees
- ELEV N/A
- BOWN N/A
- Industry
- ELEV Biotechnology: Pharmaceutical Preparations
- BOWN
- Sector
- ELEV Health Care
- BOWN
- Exchange
- ELEV Nasdaq
- BOWN Nasdaq
- Market Cap
- ELEV 37.6M
- BOWN 36.1M
- IPO Year
- ELEV 2021
- BOWN 2023
- Fundamental
- Price
- ELEV $0.26
- BOWN $7.84
- Analyst Decision
- ELEV Buy
- BOWN
- Analyst Count
- ELEV 7
- BOWN 0
- Target Price
- ELEV $3.78
- BOWN N/A
- AVG Volume (30 Days)
- ELEV 2.1M
- BOWN 373.1K
- Earning Date
- ELEV 03-06-2025
- BOWN 01-01-0001
- Dividend Yield
- ELEV N/A
- BOWN N/A
- EPS Growth
- ELEV N/A
- BOWN N/A
- EPS
- ELEV N/A
- BOWN 0.39
- Revenue
- ELEV N/A
- BOWN N/A
- Revenue This Year
- ELEV N/A
- BOWN N/A
- Revenue Next Year
- ELEV N/A
- BOWN N/A
- P/E Ratio
- ELEV N/A
- BOWN $20.62
- Revenue Growth
- ELEV N/A
- BOWN N/A
- 52 Week Low
- ELEV $0.24
- BOWN $2.71
- 52 Week High
- ELEV $5.83
- BOWN $11.00
- Technical
- Relative Strength Index (RSI)
- ELEV 23.65
- BOWN 71.24
- Support Level
- ELEV $0.24
- BOWN $6.50
- Resistance Level
- ELEV $0.55
- BOWN $7.40
- Average True Range (ATR)
- ELEV 0.04
- BOWN 0.98
- MACD
- ELEV -0.02
- BOWN 0.44
- Stochastic Oscillator
- ELEV 6.23
- BOWN 94.65
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.
About BOWN Bowen Acquisition Corp
Bowen Acquisition Corp is a blank check company.